Objective of the Phase I/II working group is the interdisciplinary conception, initiation and coordination of phase I/II studies. The consortium not only conducts investigator initiated, academic studies, but also represents a suitable portal to communicate and coordinate studies initiated by pharmaceutical companies. In addition, an interdisciplinary network has been established to perform an extensive biological study programme.
Due to the participation of a multitude of experienced European study centres, simultaneous recruitment of several trials is feasible.
Coordinator: V. Ribrag, Institute Gustave Roussy